FHTX vs HAL · rev $22.6M vs P/E 9.3, $19.05B cap
Foghorn Therapeutics Inc (FHTX) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported FHTX revenue for 2024-12-31 was $22.6M. Net income was -$86.6M. Revenue was down 33.8% from 2023-12-31 to 2024-12-31. FHTX currently screens at market cap $237.8M.
HAL does not have a complete income-statement cache yet.
FHTX currently screens at market cap $237.8M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the FHTX and HAL stock pages for the full models.
Not investment advice.